Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$15.4 - $20.16 $6.47 Million - $8.47 Million
-419,900 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.24 - $21.45 $569,088 - $669,240
31,200 Added 8.03%
419,900 $7.66 Million
Q1 2020

May 15, 2020

BUY
$16.28 - $25.63 $921,448 - $1.45 Million
56,600 Added 17.04%
388,700 $7.83 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $23.52 $3.98 Million - $4.79 Million
203,500 Added 158.24%
332,100 $7.74 Million
Q3 2019

Nov 14, 2019

SELL
$19.85 - $22.76 $1.54 Million - $1.77 Million
-77,800 Reduced 37.69%
128,600 $2.58 Million
Q2 2019

Aug 14, 2019

BUY
$17.59 - $21.1 $554,085 - $664,650
31,500 Added 18.01%
206,400 $4.36 Million
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $729,405 - $814,455
40,500 Added 30.13%
174,900 $3.52 Million
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $1.96 Million - $2.41 Million
112,100 Added 502.69%
134,400 $2.47 Million
Q3 2018

Nov 14, 2018

SELL
$19.97 - $21.96 $1.8 Million - $1.98 Million
-90,050 Reduced 80.15%
22,300 $477,000
Q2 2018

Aug 14, 2018

SELL
$20.16 - $24.68 $2.49 Million - $3.05 Million
-123,550 Reduced 52.37%
112,350 $2.42 Million
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $442,758 - $543,910
21,800 Added 10.18%
235,900 $5 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $3.22 Million - $3.66 Million
153,300 Added 252.14%
214,100 $4.91 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $1.22 Million - $1.33 Million
60,800
60,800 $1.33 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.